Carrillo, MD, discusses results of a study which sought to assess the association between thymectomy and incidence of renal ...

Recently published guidelines from the FDA aim to expand eligibility criteria in clinical trials with recommendations for ...

The FDA issued a ‘safe to proceed’ for the investigational new drug application for PRAME TCR/IL-15 NK for relapsed or ...

During a Case-Based Roundtable® Chandler H. Park, MD, led a discussion on the considerations physicians have when deciding on ...

Although immune checkpoint inhibitors have become a cornerstone of therapy across cancer settings, their use in most breast ...

Lucia Masarova, MD, PhD, elaborated on the latest updates across myeloproliferative neoplasms, focusing on significant ...

Updated guidelines for small cell lung cancer were developed with an expert panel assembled by the American Society of ...

During a live Community Case Forum event in partnership with the Tennessee Oncology Practice Society, Pierre Gholam, MD, ...

With the approval of belzutifan and other newer data for treating patients with recurrent renal cell carcinoma, the state of ...

Targeted therapies and immunotherapies across the ovarian, endometrial, and cervical cancers landscape play expanded roles, ...

In an interview with Targeted Oncology, Ben Jones identified the key challenges community oncologists are facing due to ...

During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, MBA, FACP, FCCP, discussed the role of larotrectinib in a ...